Maximus, Inc. (MMS) Director Russell A. Beliveau Sells 1,500 Shares
Maximus, Inc. (NYSE:MMS) Director Russell A. Beliveau sold 1,500 shares of the business’s stock in a transaction dated Wednesday, November 15th. The shares were sold at an average price of $64.30, for a total value of $96,450.00. Following the completion of the transaction, the director now directly owns 40,329 shares of the company’s stock, valued at approximately $2,593,154.70. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Maximus, Inc. (NYSE:MMS) traded down $0.15 during midday trading on Friday, reaching $65.47. The company had a trading volume of 327,295 shares, compared to its average volume of 267,984. The firm has a market cap of $4,240.00, a PE ratio of 20.83, a price-to-earnings-growth ratio of 2.42 and a beta of 1.32. Maximus, Inc. has a 12 month low of $51.74 and a 12 month high of $66.96.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 30th. Shareholders of record on Wednesday, November 15th will be paid a dividend of $0.045 per share. The ex-dividend date of this dividend is Tuesday, November 14th. This represents a $0.18 annualized dividend and a yield of 0.27%. Maximus’s dividend payout ratio (DPR) is currently 5.68%.
WARNING: This article was posted by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another website, it was copied illegally and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.dailypolitical.com/2017/11/18/maximus-inc-mms-director-russell-a-beliveau-sells-1500-shares.html.
A number of large investors have recently bought and sold shares of the business. Belpointe Asset Management LLC purchased a new stake in Maximus during the 3rd quarter worth approximately $269,000. Cetera Advisors LLC purchased a new stake in Maximus during the 3rd quarter worth approximately $275,000. California Public Employees Retirement System increased its stake in Maximus by 4.7% during the 3rd quarter. California Public Employees Retirement System now owns 104,587 shares of the health services provider’s stock worth $6,746,000 after buying an additional 4,687 shares in the last quarter. Cubist Systematic Strategies LLC increased its stake in Maximus by 28.5% during the 3rd quarter. Cubist Systematic Strategies LLC now owns 5,100 shares of the health services provider’s stock worth $329,000 after buying an additional 1,131 shares in the last quarter. Finally, Jane Street Group LLC purchased a new stake in Maximus during the 3rd quarter worth approximately $359,000. Institutional investors own 97.55% of the company’s stock.
Several equities analysts have recently issued reports on MMS shares. Zacks Investment Research raised Maximus from a “hold” rating to a “buy” rating and set a $73.00 price objective for the company in a report on Wednesday, October 4th. Robert W. Baird began coverage on Maximus in a report on Sunday, September 3rd. They issued a “neutral” rating for the company. Canaccord Genuity reduced their price target on Maximus from $62.00 to $61.00 and set a “hold” rating for the company in a report on Friday, November 10th. Maxim Group set a $66.00 price target on Maximus and gave the stock a “hold” rating in a report on Thursday, August 3rd. Finally, BidaskClub cut Maximus from a “hold” rating to a “sell” rating in a report on Monday, July 24th. Two investment analysts have rated the stock with a sell rating and six have given a hold rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $64.33.
Maximus Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.